Home›People›Andrea Mazzocchi
Andrea Mazzocchi

Andrea Mazzocchi

Director at Simbryo Technologies.

Director
Updated Nov 10, 2026·Latest SEC filing Jul 27, 2026·Suggest an edit

About Andrea Mazzocchi

Andrea Mazzocchi is a director at Simbryo Technologies.

Experience

This experience comes from Andrea Mazzocchi's profile and from SEC filings. For roles taken from filings, the years are when the filings name Andrea Mazzocchi in the role, so the role may have started earlier or lasted longer.

Simbryo Technologies, Inc. Current
Director
2026 – Present · Houston, TX
Fertility testing for patients and physicians using models of patients' uterine lining.
SpringTide Ventures Current
Venture Partner
2026 – Present
Paceline Bio Current
CEO & Co-Founder
2025 – Present
Eris Biotech (YC W24) Current
Advisor
2025 – Present
The Chick Mission Current
Committee Member
2025 – Present
Whelix Current
Advisor
2024 – Present
Mazzocchi BioConsulting, LLC
Consultant
2024 – 2025
Pathos
Vice President, Partnerships
2023 – 2024
Known Medicine
CEO & Co-Founder (acquired by Pathos AI)
2020 – 2023
Wake Forest University
Adjunct Lecturer
2020 – 2022
Wake Forest Institute for Regenerative Medicine
Doctoral Candidate/Graduate Research Assistant
2016 – 2020
The Janssen Pharmaceutical Companies of Johnson & Johnson
Primary Containers & Devices Co-op
2015
GE Healthcare
Magnetic Resonance Systems Intern
2013
GE Transportation
Marketing Intelligence Analyst Intern
2012

Key Colleagues at Startups

The people Andrea Mazzocchi works with at each company, as listed on that company's latest Form D.

Simbryo Technologies, Inc. · Form D, Jul 27, 2026
Aryeh Warmflash
Aryeh Warmflash
Chief Science Officer
SR
Yael Katz
Yael Katz
Chief Executive Officer and director

Sources

  1. SECSimbryo Technologies, Inc. Form D, filed Jul 27, 2026